Document is current
Any future updates will be listed below
-
Authors
Corradini, S. https://orcid.org/0000-0002-5990-806X
Maksimos, M. https://orcid.org/0009-0006-9354-6556
Azab, F.
Arsalani, S.
Nwarunma, E. https://orcid.org/0009-0009-2543-2508
Watt, G.
Soutar, R.
Powell, M.
Henderson, R.
Travers, J.
Chen, Z.
Wang, S. https://orcid.org/0000-0002-8782-6950
Azab, A. K. https://orcid.org/0000-0002-6371-2780
Williams, M. T. S. https://orcid.org/0000-0003-1114-1418
-
Funding
Funding for this research was provided by:
Glasgow Caledonian University Sylvia Aitken Charitable Trust
Cancer Prevention and Research Institute of Texas (RR220088)
- License Information
-
More Information
Article History
Received: 18 November 2025
Revised: 28 April 2026
Accepted: 2 June 2026
First Online: 16 June 2026
Competing interests
: Dr. Azab is the founder and owner of Cellatrix LLC that has an exclusive license for the 3DTEBM technology described in part of the experiments in this paper; however, Cellatrix has no contribution to this study. Other authors state no conflicts of interest.
